Sulfiredoxin levels in gingival crevicular fluid: A new antioxidant defence system- case control study.

J Oral Biol Craniofac Res · 2025 · PMC12396553 · PMID 40895269

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

For Group I there is a highly significant reduction in Srx levels at baseline (0.505 ± 0.20 ng/ml) to 3 months (0.301 ± 0.13 ng/ml) with the p-value of 0.005.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.